Apeiron Investment Group
Apeiron is an investment firm that provides financial services for fintech, real estate and media sectors.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Apeiron Investment Group Information
Geographic Data
Address:
City: Sliema
State: NA - Malta
Zip:
Country: Malta
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
3,467,925Website Global Rank
4,132Website Monthly Traffic
Twitter Followers
Description
Apeiron is an investment firm that provides financial services for fintech, real estate and media sectors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2021 | Jasper Therapeutics | Post-IPO Equity | 0 |
| 12/2020 | Isar Aerospace | Series B | 91M |
| 11/2021 | Mynaric | Post-IPO Equity | 0 |
| 9/2021 | Olsam Group | Series A | 0 |
| 11/2020 | ATAI Life Sciences | Series C | 0 |
| 6/2021 | Ksana Health | Seed | 2M |
| 9/2021 | Upmin | Seed Round | 0 |
| 3/2021 | ATAI Life Sciences | Series D | 0 |
| 3/2021 | Chemomab | Post-IPO Equity | 45.5M |
| 1/2018 | Juvenescence | Seed Round | 12.3M |
| 10/2020 | Sensei Biotherapeutics | Series A | 0 |
| 5/2021 | Alto Neuroscience | Series A | 0 |
| 2/2021 | Cambrian Biopharma | Series B | 0 |
| 1/2021 | Sensei Biotherapeutics | Series B | 0 |
| 3/2019 | ATAI Life Sciences | Series B | 43M |
| 12/2020 | MagForce | Post-IPO Equity | 5.7M |
| 10/2021 | Cambrian Biopharma | Series C | 0 |
| 3/2022 | Rejuveron Life Sciences | Series B | - |
| 7/2021 | Isar Aerospace | Series B | 0 |
| 7/2017 | Brolly | Seed Round | 1.3M |
| 11/2019 | Hotelbird | Seed Round | 0 |
| 8/2019 | Zenhomes | Series A | 0 |
| 8/2019 | Springlane | Series C | 0 |
| 11/2021 | Mynaric | Post-IPO Equity | 0 |
| 10/2021 | Cambrian Biopharma | Series C | 0 |
| 9/2021 | Jasper Therapeutics | Post-IPO Equity | 0 |
| 9/2021 | Upmin | Seed Round | 0 |
| 9/2021 | Olsam Group | Series A | 0 |
| 7/2021 | Isar Aerospace | Series B | 0 |
| 6/2021 | Ksana Health | Seed Round | 0 |
| 5/2021 | Alto Neuroscience | Series A | 0 |
| 3/2021 | Chemomab | Post-IPO Equity | 0 |
| 3/2021 | ATAI Life Sciences | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
